Elected to the Board of European Technology Platform - NanoMedicine

Our Founder and CEO Dr Su Metcalfe is elected to the Board of the European Technology Platform - NanoMedicne (ETPN)

NME19 ETPN ExBo 2019-2021.jpg

The ETPN is a key element in the European Union acting as a main bridge between the community and the European Commission to implement Research FrameWork Programmes. As the "Think Tank of NanoMedicine in Europe", Su's election is further recognition of the world-leading position of LIFNano Therapeutics as we move toward delivering LIFNano to patients.

Arnold Kristoff